Overview and Scope
4D bioprinting is an advanced manufacturing technology that integrates 3D bioprinting with dynamic functionalities, enabling the fabrication of biomimetic structures capable of changing shape or function over time in response to external stimuli. 4D bioprinting allows for the creation of tissues and structures that can mimic the dynamic functionalities of natural tissues
Sizing and Forecast
The 4D bioprinting market size has grown exponentially in recent years. It will grow from $.07 billion in 2023 to $0.09 billion in 2024 at a compound annual growth rate (CAGR) of 30.3%. The growth in the historic period can be attributed to rise in geriatric population, increasing healthcare expenditure, rise in 3D bioprinting startups, increasing investments in R&D, growing prevalence of chronic diseases.
The 4D bioprinting market size is expected to see exponential growth in the next few years. It will grow to $0.26 billion in 2028 at a compound annual growth rate (CAGR) of 29.9%. The growth in the forecast period can be attributed to increasing demand for organ transplant, rising aging population, increasing prevalence of chronic diseases, increasing healthcare expenditure, rising demand for personalized medicine. Major trends in the forecast period include technological advancements, collaborations between academia and industry, integration of artificial intelligence, shift towards decentralized manufacturing, integration with 3D imaging technologies.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/4d-bioprinting-global-market-report
The 4D bioprinting market covered in this report is segmented –
1) By Type Of Technology: Extrusion-Based Technology, Laser-Based Technology, Inkjet-Based Technology, Other Types
2) By Application Area: Biomedical Application, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Academic Research And Development, Other End-Users
North America was the largest region in the 4D bioprinting market in 2023. The regions covered in the 4D bioprinting market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=14235&type=smp
Major Driver Impacting Market Growth
The increasing demand for organ transplants is expected to propel the growth of the 4D bioprinting market going forward. Organ transplants involve surgically removing an organ or tissue from one person (the donor) and placing it in another person (the recipient) who needs that organ due to organ failure or dysfunction. The demand for organ transplants arises from the critical need to save lives and improve the quality of life for individuals suffering from organ failure or dysfunction. Organ transplants use 4D bioprinting to advance regenerative medicine by precisely fabricating complex tissues and organs with functional capabilities, offering hope for addressing the shortage of donor organs and improving transplant outcomes. For instance, in January 2022, according to the Organ Procurement and Transplantation Network (OPTN), a US-based government organization, in 2021, the number of organ transplantations conducted in the United States reached 41,354, marking a 5.90% rise from the prior year. Therefore, the increasing demand for organ transplants is driving the growth of the 4D bioprinting market.
4D Bioprinting’s Role In Driving The Growth Of Personalized Medicine
The rising demand for personalized medicine is expected to fuel the growth of the 4D bioprinting market going forward. Personalized medicine refers to a medical approach that tailors healthcare decisions, practices, interventions, and treatments to individual characteristics of each patient. 4D bioprinting plays a crucial role in personalized medicine by enabling the fabrication of smart, environmentally responsive biological structures, tissues, and organs that can adapt to various environmental changes. For instance, in 2022, according to Personalized Medicine Coalition, a US-based professional membership organization, the approval of 12 new personalized medicines accounted for about 34% of all newly approved therapies, marking a significant uptick from prior years. Therefore, the rising demand for personalized medicine is driving the growth of the 4D bioprinting market.
Key Industry Players
Major companies operating in the 4D bioprinting market are 3D Systems Corporation, CELLINK AB, EnvisionTEC Inc., Advanced Solutions Life Sciences, Nanoscribe, Aspect Biosystems Ltd., Aleph Farms, BioBots Inc., Sculpteo, Prellis Biologics, Rokit Healthcare, Cyfuse Biomedical, 3D Bioprinting Solutions, 4D Biomaterials Ltd., Allevi Inc., Cellenion, FluidForm, Methuselah Health, Nanofabrica, OxSyBio Ltd., Poietis S.A.S., REGEMAT 3D S.L., Replicel Life Sciences Inc., VIVAX BIO, Organovo Holdings Inc.
The 4d bioprinting market report table of contents includes:
1. Executive Summary
2. 4D Bioprinting Characteristics
3. 4D Bioprinting Trends And Strategies
4. 4D Bioprinting – Macro Economic Scenario
5. Global 4D Bioprinting Size and Growth
…..
32. Global 4D Bioprinting Competitive Benchmarking
33. Global 4D Bioprinting Competitive Dashboard
34. Key Mergers And Acquisitions In The 4D Bioprinting
35. 4D Bioprinting Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
